Methodological Considerations on Targeted Polymer Embolization in Obstructive Hypertrophic Cardiomyopathy

Key Points

• This trial aims to evaluate the efficacy of targeted polymer embolization in patients with obstructive hypertrophic cardiomyopathy.
• Conducted as a randomized clinical trial
• Involved patients with obstructive hypertrophic cardiomyopathy
• Analyzed the impact of polymer embolization on cardiac function
• Demonstrated significant improvement in cardiac function post-embolization, with a 25% increase in peak oxygen consumption (p<0.01).
• Reduction in left ventricular outflow tract gradients observed, with a mean decrease of 30 mmHg (95% CI, 20-40 mmHg, p<0.001).